Log in

OTCMKTS:ENOBEnochian Biosciences Stock Price, Forecast & News

$3.92
+0.15 (+3.98 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.82
Now: $3.92
$3.99
50-Day Range
$3.46
MA: $3.89
$6.06
52-Week Range
$1.95
Now: $3.92
$13.43
Volume55,900 shs
Average Volume259,749 shs
Market Capitalization$182.27 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Enochian Biosciences Inc., a biopharmaceutical company, identifies, develops, manufactures, and commercializes gene therapies for HIV/AIDS and cancer patients. Its lead candidate include ENO-1001 a genetically modified cell therapy for patients with HIV/AIDS. It is also developing ENO-2001, an HIV vaccine; and additional compounds, such as ENO-4001, ENO-4002, ENO-3001, and ENO-5001 that are in discovery stage for prevention of relapse in colon cancer patients. Enochian BioSciences is headquartered in Los Angeles, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ENOB
CUSIPN/A
CIKN/A
Phone510-203-4857

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$182.27 million
Next Earnings DateN/A
OptionableNot Optionable

Receive ENOB News and Ratings via Email

Sign-up to receive the latest news and ratings for ENOB and its competitors with MarketBeat's FREE daily newsletter.

Enochian Biosciences (OTCMKTS:ENOB) Frequently Asked Questions

How has Enochian Biosciences' stock been impacted by COVID-19 (Coronavirus)?

Enochian Biosciences' stock was trading at $2.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ENOB stock has increased by 74.2% and is now trading at $3.92. View which stocks have been most impacted by Coronavirus.

How were Enochian Biosciences' earnings last quarter?

Enochian Biosciences Inc (OTCMKTS:ENOB) announced its quarterly earnings data on Monday, May, 11th. The company reported ($0.03) EPS for the quarter. View Enochian Biosciences' earnings history.

Has Enochian Biosciences been receiving favorable news coverage?

Press coverage about ENOB stock has trended neutral recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Enochian Biosciences earned a daily sentiment score of 0.4 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Enochian Biosciences.

Who are some of Enochian Biosciences' key competitors?

What other stocks do shareholders of Enochian Biosciences own?

What is Enochian Biosciences' stock symbol?

Enochian Biosciences trades on the OTCMKTS under the ticker symbol "ENOB."

How do I buy shares of Enochian Biosciences?

Shares of ENOB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Enochian Biosciences' stock price today?

One share of ENOB stock can currently be purchased for approximately $3.92.

How big of a company is Enochian Biosciences?

Enochian Biosciences has a market capitalization of $182.27 million.

What is Enochian Biosciences' official website?

The official website for Enochian Biosciences is www.enochianbio.com.

How can I contact Enochian Biosciences?

The company can be reached via phone at 510-203-4857.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.